Iptacopan, also known as LNP023, is the first oral small moleculecompletion factor B (CFB) inhibitor developed by Novartis Pharma AG.

The study proposes new strategies for predicting tumor immunotherapy efficacy based on multi-omics studies.

On July 26, 2023, Astellas and PeptiDream announced that they have entered into a research collaboration and licensing agreement to discover innovative protein degradation drugs for two targets selected by Astellas.

On July 26, 2023, Tarsus Pharmaceuticals announced that the U.S. FDA has approved Xdemvy (lotilaner ophthalmic solution, 0.25%) for the treatment of Demodex blepharitis.

Empagliflozin is the first Sodium-Glucose Co-Transporter-2 (SGLT2) inhibitor to statistically significantly reduce the risk of hospitalization for any cause compared to a placebo in patients with CKD.

PRGN-2012 is a therapeutic vaccine that achieves therapeutic effects through immune stimulation.

Vertex Pharmaceuticals, Inc. is a biopharmaceutical company that was founded in 1989 and is headquartered in Massachusetts, United States.

A recent study has found that elevated levels of the protein MAP1B result in neuronal autophagy defects closely linked to human ASD. Treating FXS and ASD with rapamycin, a drug that inhibits autophagy, may be a promising potential therapy.

Otsuka Holdings Co., Ltd. is a pharmaceutical organization based in Tokyo-to, Japan. It was founded in 1921 and has since become a prominent player in the biomedicine industry.

These limitations include the absence of high-resolution structures for numerous proteins, the challenge of accurately predicting active sites, defining binding pockets for novel targets with multiple domains, and anticipating allosteric sites.

Daiichi Sankyo Co., Ltd. is a pharmaceutical organization founded in 2005 and based in Tokyo, Japan. The company operates in the field of biomedicine and has a diverse portfolio of drugs targeting various therapeutic areas.

On July 23, CanSino Biologics announced that its recombinant shingles vaccine CS-2032, developed in collaboration with Vaccitech, has received clinical trial approval from Health Canada.